Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Revenues up 239% over prior year fiscal second quarter Customer orders backlog of over $4.0 million at November 30, 2021 Walmart began in-store and online sales of Biomerica’s EZ Detect™ Colon...
-
InFoods® IBS Clinical Trial on Track for Completion in December with Topline Results Expected to be Announced in January, 2022. IRVINE, Calif., Dec. 16, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc....
-
Chaired by Dr. Brooks Cash, Chief of Gastroenterology and Hepatology at the University of Texas Health Center at HoustonScientific Advisory Board to guide on programs to screen and test patients in US...
-
Studies show that 13-20% of Canadians suffer from IBS at any given time1. The lifetime risk for a Canadian to develop IBS is 30%1. IRVINE, Calif., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc....
-
Simple at-home breast exam device provides results within minutesStudies show increase in Breast Exam Sensitivity IRVINE, Calif. , Oct. 29, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA)...
-
Over 4,600 Walmart Stores to sell the EZ Detect™ productSimple 2 minute at-home test detects early warning sign of colorectal cancer IRVINE, Calif., Oct. 19, 2021 (GLOBE NEWSWIRE) --...
-
Revenues up 10% over fiscal first quarter 2021, and 20% over fiscal fourth quarter 2021 Customer orders backlog of over $1.5 million at August 31, 2021 Following close of first fiscal quarter...
-
Simple 2 minute at-home test detects early warning sign of colorectal cancer IRVINE, Calif., Oct. 01, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) (the “Company”) today announced...
-
Final patients to compete this double blinded trial by end of October. Top-Line trial results expected by year end.The InFoods® IBS Diagnostic-Guided Therapy is the first therapy of its kind for...
-
Revenues increase 7.6% for fiscal 2021 vs fiscal 2020.InFoods® IBS Endpoint Trial expected to be fully enrolled in less than 2 weeks.Biomerica receives multiple notices of allowance for patents...